Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of Depo-ProveraR to women.

× No keyword cloud information.

13 in total

Review 1. Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors: Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal: Endocr Rev Date: 2018-02-01 Impact factor: 19.871

Review 2. Premenopausal women and low bone density.

Authors: Aliya Khan
Journal: Can Fam Physician Date: 2006-06 Impact factor: 3.275

3. Relationship between weight and bone mineral density in adolescents on hormonal contraception.

Authors: Andrea E Bonny; Michelle Secic; Barbara A Cromer
Journal: J Pediatr Adolesc Gynecol Date: 2010-08-14 Impact factor: 1.814

4. A pilot study of depot medroxyprogesterone acetate pharmacokinetics and weight gain in adolescent females.

Authors: Andrea E Bonny; Hannah L H Lange; Lynette K Rogers; Dave M Gothard; Michael D Reed
Journal: Contraception Date: 2014-02-01 Impact factor: 3.375

5. A longitudinal comparison of body composition changes in adolescent girls receiving hormonal contraception.

Authors: Andrea E Bonny; Michelle Secic; Barbara A Cromer
Journal: J Adolesc Health Date: 2009-06-21 Impact factor: 5.012

Review 6. Long acting contraceptives. Present status.

Authors: G Benagiano; F M Primiero
Journal: Drugs Date: 1983-06 Impact factor: 9.546

7. Medroxyprogesterone acetate bioavailability after high-dose intraperitoneal administration in advanced cancer.

Authors: C M Camaggi; E Strocchi; B Costanti; P Beghelli; P Ferrari; F Pannuti
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

8. Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma.

Authors: E Vesterinen; N E Backas; K Pesonen; U H Stenman; T Laatikainen
Journal: Arch Gynecol Date: 1981

9. Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?

Authors: Chelsea B Polis; Sharon L Achilles; Zdenek Hel; Janet P Hapgood
Journal: Contraception Date: 2017-12-11 Impact factor: 3.375

10. Oral high-dose medroxyprogesterone acetate (MAP) in treatment of advanced breast cancer. A preliminary report of clinical and experimental studies.

Authors: M Izuo; Y Iino; K Endo
Journal: Breast Cancer Res Treat Date: 1981 Impact factor: 4.872